Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 12/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.45 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.41 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.38 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.38 |
| ▸ | PRKDC | P78527 | 1/20 | 0.36 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.35 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.35 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.34 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.34 |
| ▸ | HTR2C | P28335 | 1/20 | 0.34 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24056358 | 1.00 | LIMK1 (0.47) | LIMK1ALOX5DNPH1CDK5CDK5R1 | |
| SCHEMBL25473221 | 1.00 | LIMK1 (0.47) | LIMK1ALOX5DNPH1CDK5CDK5R1 | |
| SCHEMBL25473259 | 1.00 | LIMK1 (0.47) | LIMK1ALOX5DNPH1CDK5CDK5R1 | |
| SCHEMBL25473431 | 0.97 | LIMK1 (0.49) | LIMK1ALOX5DNPH1CDK5CDK5R1 | |
| SCHEMBL19038427 | 0.94 | LIMK1 (0.53) | LIMK1ALOX5DNPH1CDK5CDK5R1 | |
| SCHEMBL19038457 | 0.94 | LIMK1 (0.53) | LIMK1ALOX5DNPH1CDK5CDK5R1 | |
| SCHEMBL19038458 | 0.94 | LIMK1 (0.53) | LIMK1ALOX5DNPH1CDK5CDK5R1 | |
| SCHEMBL19038435 | 0.93 | LIMK1 (0.51) | LIMK1ALOX5DNPH1CDK5CDK5R1 | |
| SCHEMBL24056367 | 0.92 | LIMK1 (0.57) | LIMK1ALOX5DNPH1CDK5CDK5R1 | |
| SCHEMBL24056368 | 0.92 | LIMK1 (0.57) | LIMK1ALOX5DNPH1CDK5CDK5R1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230147615-A1 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2023-05-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230147615-A1 | ORGANIC COMPOUND, LIGHT-EMITTING DEVICE, LIGHT-EMITTING APPARATUS, ELECTRONIC APPLIANCE, AND LIGHTING DEVICE | CRY1, H1-0, OLA1 | LIMK1 2823/4885ALOX5 1738/4885DNPH1 2539/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.